ARRAY Technologies Bolsters Board With Two Additional Directors
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Wall St edges lower as chips fall; markets assess big bank earnings
- Oil prices ease as US-Russia diesel deal hopes offset Middle East attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
| Array Biopharma, Inc. (NASDAQ: ARRY) | Delayed: 3.55 -0.05 (1.39%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.60 | 52 Week High | $7.27 | |||
| Open | $3.57 | 52 Week Low | $2.39 | |||
| Day High | $3.65 | P/E | N/A | |||
| Day Low | $3.54 | EPS | $-0.61 | |||
| Volume | 2,140,729 | |||||
